The fund company ARK of the US investor Cathie Wood, known for its focus on disruptive technologies, is now expanding into Europe. Three new fund products have been launched, which from Thursday will be traded on the Frankfurt Stock Exchange as well as other European trading venues. These funds are specifically designed in accordance with European regulations and offer investors the opportunity to invest in forward-looking technologies.

The new funds include variants of the well-known ARK Innovation and ARK Genomic Revolution, and an ARK Intelligence & Robotics specifically developed for Europe. Each of these funds aims to invest in companies that could potentially change the world through the introduction of new technological products or services.

Despite the Cult Status ARK Achieved During the Pandemic, as ARK Innovation Saw Significant Price Gains, Analysts Warn of the Volatility of These Investments. The Performance of ARK Innovation Has Recently Flattened, Partly Due to the High Allocation of Tesla Shares, Which Have Suffered Significant Losses This Year.

According to Scope Analysis, these new funds are "not for the faint-hearted," as they can be subject to significant fluctuations. The expense ratio of the funds is 0.75 percent per year, positioning them between traditional index ETFs and actively managed global equity funds.

This Expansion Represents a Significant Development for ARK, Which is Now Attempting to Gain a Foothold in the European Market After Challenging Years. The Investment Company Stresses That It is Bringing Its Best Ideas and a Decades-Long Track Record of Success to Europe, Supported by a First-Class Product and Distribution Team.